Ignacio Gil-Bazo

10PUBLICATIONS
72CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Food properties (incl. characteristics and health benefits)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Feb 28, 2024
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells.

Xiangnan Guan, Ruozhen Hu, Yoonha Choi

|Oct 10, 2023
Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancer.

Irati Macaya, Marta Roman, Connor Welch

|Mar 22, 2023
Initial Evidence for the Efficacy of Naporafenib in Combination With Trametinib in NRAS-Mutant Melanoma: Results From the Expansion Arm of a Phase Ib, Open-Label Study.

Filippo de Braud, Christophe Dooms, Rebecca S Heist

|Aug 22, 2022
The Armed Conflict and the Impact on Patients With Cancer in Ukraine: Urgent Considerations.

Christian Caglevic, Christian Rolfo, Ignacio Gil-Bazo

|Jul 09, 2022
Impact on the Nutritional Status and Inflammation of Patients with Cancer Hospitalized after the SARS-CoV-2 Lockdown.

Patricia Yárnoz-Esquíroz, Ana Chopitea, Laura Olazarán

Pageof 2